LeiomyosarcomaAmerican Journal of Cancer - Tập 5 Số 2 - Trang 81-91 - 2006
Igor Matushansky, Martee L. Hensley
Current Status and Future Prospects of Gene TherapyAmerican Journal of Cancer - - 2012
Karl D. Lewis, Tahl N. Humes, Rene Gonzalez
Since the discovery of DNA and the subsequent recognition that genetic defects
(either inherited or acquired) can be responsible for various disease states,
the concept of gene therapy has been extremely appealing. However, despite
intensive work in this field of medicine, gene therapy has yet to make a major
impact on the treatment of patients. Many technical challenges exist that must
be overcom... hiện toàn bộ
Metastatic Prostate CancerAmerican Journal of Cancer - Tập 2 - Trang 87-94 - 2012
Brian M. Levin, David J. Vaughn, Bruce S. Malkowicz
The treatment of metastatic prostate cancer is based upon the principle that
prostate cancer growth is stimulated by androgens. Androgen ablation therapy is
an effective treatment for metastatic prostate cancer. The timing of initiation
of androgen ablation and the role of combined androgen blockade have been
investigated. The utilization of intermittent androgen suppression offers the
potential f... hiện toàn bộ
Pain control with zoledronic acid in patients with breast cancer and metastatic bone diseaseAmerican Journal of Cancer - Tập 3 - Trang 257-263 - 2012
Cinzia Nigro, Michela Donadio, Mara Ardine, Alessandra Beano, Marinella Mistrangelo, Zaira Coccorullo, Oscar Bertetto
Effective management of pain associated with metastatic bone disease is
paramount in the care of cancer patients. Bisphosphonates are recommended in
treating skeletal complications and there is evidence that they also control
pain. To investigate the effects of zoledronic acid, a potent
nitrogen-containing bisphosphonate, in reducing pain in patients with advanced
breast cancer and bone metastases... hiện toàn bộ
GemcitabineAmerican Journal of Cancer - Tập 4 - Trang 395-416 - 2012
James E. Frampton, Antona J. Wagstaff
Gemcitabine (Gemzar®), an intravenously administered deoxycitidine analog, is
approved in the US and several European countries for the treatment of locally
advanced (unresectable) or metastatic adenocarcinoma of the pancreas, including
fluorouracil-refractory disease. Although gemcitabine demonstrates only modest
activity against pancreatic tumors (like most other cytotoxic agents), and
rarely pr... hiện toàn bộ
Postmenopausal Metastatic Breast CancerAmerican Journal of Cancer - - 2012
Laura Assersohn, Stephen R.D. Johnston
Endocrine therapy and chemotherapy play important roles in the management of
postmenopausal women with metastatic breast cancer. This paper specifically
reviews the indications and options for first-line treatment of metastatic
breast cancer and recent advances are highlighted, with particular attention to
randomized, controlled, phase III clinical trials. Until recently, tamoxifen was
standard fi... hiện toàn bộ
AcknowledgmentAmerican Journal of Cancer - Tập 4 - Trang 347-348 - 2012
The Evolving Role of Aromatase Inhibitors in the Adjuvant Breast Cancer SettingAmerican Journal of Cancer - Tập 2 - Trang 13-18 - 2012
Paul E. Goss
Third-generation aromatase inhibitors (AIs) have shown at least equivalent or
superior efficacy to tamoxifen in the first-line treatment of women with
hormone-dependent metastatic breast cancer. Similar results have been obtained
in the neoadjuvant setting. These studies suggested that AIs may also have
significant efficacy in the adjuvant setting, and evaluation against tamoxifen
is ongoing. Unli... hiện toàn bộ
DocetaxelAmerican Journal of Cancer - Tập 3 - Trang 325-332 - 2012
Susan J. Keam, Lesley J. Scott
▴ Docetaxel is an antimicrotubule agent established as a first- and/or
second-line intravenous therapy in a variety of cancers, including locally
advanced or metastatic breast cancer. It also is approved in the US as adjuvant
therapy in early breast cancer, and continues to be investigated in this setting
in combination with other agents and in various dosing schedules. ▴ The efficacy
of docetaxel... hiện toàn bộ
Oral Chemotherapy for the Older Patient with CancerAmerican Journal of Cancer - Tập 1 - Trang 101-108 - 2012
Ignazio Carreca, Lodovico Balducci
Oral chemotherapy presents a number of theoretical advantages in older cancer
patients, including convenience of administration and dosage flexibility. Of the
oral fluorinated pyrimidines, capecitabine is the most promising, because it
minimizes the exposure of normal tissue to the active drug and substantially
reduces the risk of mucositis, that is particularly common and severe in the
aged. Desp... hiện toàn bộ